Cystic fibrosis gene therapy (CFTR-cationic liposome complex)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCystic fibrosis gene therapy (CFTR-cationic liposome complex)
Drug Alias NameCFTR gene-cationic liposome complex
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator stimulants
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A